1. Home
  2. NEWP vs NGNE Comparison

NEWP vs NGNE Comparison

Compare NEWP & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWP
  • NGNE
  • Stock Information
  • Founded
  • NEWP 1972
  • NGNE 2003
  • Country
  • NEWP Canada
  • NGNE United States
  • Employees
  • NEWP N/A
  • NGNE N/A
  • Industry
  • NEWP
  • NGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEWP
  • NGNE Health Care
  • Exchange
  • NEWP Nasdaq
  • NGNE Nasdaq
  • Market Cap
  • NEWP 185.4M
  • NGNE 257.1M
  • IPO Year
  • NEWP N/A
  • NGNE N/A
  • Fundamental
  • Price
  • NEWP $1.25
  • NGNE $16.80
  • Analyst Decision
  • NEWP Strong Buy
  • NGNE Strong Buy
  • Analyst Count
  • NEWP 1
  • NGNE 6
  • Target Price
  • NEWP $5.00
  • NGNE $60.80
  • AVG Volume (30 Days)
  • NEWP 288.7K
  • NGNE 162.7K
  • Earning Date
  • NEWP 05-06-2025
  • NGNE 05-09-2025
  • Dividend Yield
  • NEWP N/A
  • NGNE N/A
  • EPS Growth
  • NEWP N/A
  • NGNE N/A
  • EPS
  • NEWP N/A
  • NGNE N/A
  • Revenue
  • NEWP N/A
  • NGNE $925,000.00
  • Revenue This Year
  • NEWP N/A
  • NGNE N/A
  • Revenue Next Year
  • NEWP N/A
  • NGNE N/A
  • P/E Ratio
  • NEWP N/A
  • NGNE N/A
  • Revenue Growth
  • NEWP N/A
  • NGNE N/A
  • 52 Week Low
  • NEWP $0.93
  • NGNE $14.42
  • 52 Week High
  • NEWP $2.53
  • NGNE $74.49
  • Technical
  • Relative Strength Index (RSI)
  • NEWP 59.56
  • NGNE 44.93
  • Support Level
  • NEWP $1.01
  • NGNE $15.69
  • Resistance Level
  • NEWP $1.10
  • NGNE $18.62
  • Average True Range (ATR)
  • NEWP 0.09
  • NGNE 1.06
  • MACD
  • NEWP 0.02
  • NGNE 0.14
  • Stochastic Oscillator
  • NEWP 93.10
  • NGNE 37.88

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Share on Social Networks: